Akari Therapeutics (AKTX) Stock Chart & Stock Price History $0.93 -0.05 (-4.74%) Closing price 10/2/2025 03:59 PM EasternExtended Trading$0.95 +0.01 (+1.32%) As of 08:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Akari Therapeutics Stock Price Performance The Akari Therapeutics (AKTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 68.88%, with a year-to-date return of -23.47%. In the past month, the stock has increased 42.55%, reflecting recent market activity. As of the latest close, Akari Therapeutics traded at $0.93 with a market cap of $30.46 million and volume of 37,289 shares. Five years ago, the stock traded at a split-adjusted price of $34.60, representing a 97.30% decrease over that period. At the time, it had a market cap of $27.43 million and a volume of 5,477 shares. Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-3.75%1 Month Performance+42.55%3 Month Performance-20.87%Year-To-Date Performance-23.47%1 Year Performance-68.88%5 Year Performance-97.30% AKTX Stock Chart for Friday, October, 3, 2025 AKTX Chart by TradingView Akari Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/02/2025$0.98$0.93-4.74%$0.98$0.9337,289 shs$30.46 million10/01/2025$1.01$0.98-2.95%$1.04$0.9651,509 shs$31.97 million09/30/2025$1.02$1.01-1.08%$1.08$0.9877,166 shs$32.95 million09/29/2025$0.97$1.02+5.25%$1.11$0.91275,635 shs$33.31 million09/26/2025$1.12$0.97-13.38%$1.15$0.91205,373 shs$31.65 million09/25/2025$1.11$1.12+0.90%$1.24$1.04509,852 shs$36.53 million09/24/2025$0.76$1.11+45.96%$1.22$0.763.65 million shs$36.21 million09/23/2025$0.82$0.76-7.15%$0.81$0.7481,860 shs$24.81 million09/22/2025$0.81$0.82+0.82%$0.83$0.8020,673 shs$26.72 million09/19/2025$0.80$0.81+1.52%$0.85$0.8030,133 shs$26.50 million Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/18/2025$0.79$0.80+0.83%$0.91$0.78305,476 shs$26.10 million09/17/2025$0.76$0.79+5.11%$0.83$0.683.40 million shs$25.89 million09/16/2025$0.78$0.76-2.64%$0.80$0.7543,417 shs$24.63 million09/15/2025$0.79$0.78-1.71%$0.80$0.7615,037 shs$25.30 million09/12/2025$0.77$0.79+2.47%$0.80$0.7525,690 shs$25.74 million09/11/2025$0.79$0.77-2.53%$0.79$0.76109,042 shs$25.12 million09/10/2025$0.84$0.79-5.96%$0.88$0.78152,207 shs$25.77 million09/09/2025$0.85$0.84-1.16%$0.89$0.8336,987 shs$27.40 million09/08/2025$0.82$0.85+3.82%$0.85$0.8075,111 shs$27.73 million09/05/2025$0.73$0.82+12.15%$0.82$0.6963,466 shs$26.35 million09/04/2025$0.66$0.73+11.45%$0.75$0.66109,141 shs$23.49 million09/03/2025$0.70$0.66-6.42%$0.69$0.63140,540 shs$21.08 million09/02/2025$0.76$0.70-7.91%$0.77$0.57571,228 shs$22.52 million Related Companies Surrozen Stock Chart HilleVax Stock Chart MEI Pharma Stock Chart Anebulo Pharmaceuticals Stock Chart Cognition Therapeutics Stock Chart MacroGenics Stock Chart TScan Therapeutics Stock Chart Alto Neuroscience Stock Chart aTyr Pharma Stock Chart ImmunoPrecise Antibodies Stock Chart Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKTX) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredChina’s message to TrumpPorter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKTX Stock Alerts